Frequency of First Generic Drug Approvals With “Skinny Labels” in the United States

Podobne zapisy

• Paying Physicians to Prescribe Generic Drugs and Follow-On Biologics in the United States
  od: Sarpatwari, Ameet, i wsp.
  Wydane: (2015)
• Regulatory Solutions to the Problem of High Generic Drug Costs
  od: Luo, Jing, i wsp.
  Wydane: (2015)
• The Case for Reforming Drug Naming: Should Brand Name Trademark Protections Expire upon Generic Entry?
  od: Sarpatwari, Ameet, i wsp.
  Wydane: (2016)
• Assessment of Variation in State Regulation of Generic Drug and Interchangeable Biologic Substitutions
  od: Sacks, Chana A., i wsp.
  Wydane: (2020)
• Federal Spending on Off-Patent Drugs That Lack Generic Competition
  od: Rome, Benjamin N., i wsp.
  Wydane: (2020)